Mahon Paul A.'s most recent trade in United Therapeutics Corp was a trade of 8,300 Common Stock done at an average price of $146.0 . Disclosure was reported to the exchange on June 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 04 Jun 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2026 | 8,300 | 105,640 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 546.42 per share. | 04 Jun 2026 | 2,627 | 49,431 (0%) | 0% | 546.4 | 1,435,440 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 548.42 per share. | 04 Jun 2026 | 1,481 | 47,015 (0%) | 0% | 548.4 | 812,217 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 549.47 per share. | 04 Jun 2026 | 1,250 | 45,172 (0%) | 0% | 549.5 | 686,838 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 547.11 per share. | 04 Jun 2026 | 935 | 48,496 (0%) | 0% | 547.1 | 511,549 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 543.89 per share. | 04 Jun 2026 | 840 | 52,432 (0%) | 0% | 543.9 | 456,867 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 549.49 per share. | 04 Jun 2026 | 593 | 46,422 (0%) | 0% | 549.5 | 325,850 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 545.27 per share. | 04 Jun 2026 | 374 | 52,058 (0%) | 0% | 545.3 | 203,930 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 539.76 per share. | 04 Jun 2026 | 200 | 53,272 (0%) | 0% | 539.8 | 107,952 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2026 | 8,300 | 113,940 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 21 May 2026 | 8,000 | 53,472 (0%) | 0% | 146.0 | 1,168,240 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 561.99 per share. | 21 May 2026 | 2,178 | 50,334 (0%) | 0% | 562.0 | 1,224,015 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 564.06 per share. | 21 May 2026 | 2,015 | 46,993 (0%) | 0% | 564.1 | 1,136,573 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 562.93 per share. | 21 May 2026 | 1,326 | 49,008 (0%) | 0% | 562.9 | 746,449 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 565.20 per share. | 21 May 2026 | 1,251 | 45,742 (0%) | 0% | 565.2 | 707,059 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 557.85 per share. | 21 May 2026 | 640 | 52,712 (0%) | 0% | 557.9 | 357,024 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 21 May 2026 | 300 | 45,472 (0%) | 0% | 146.0 | 43,809 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 562.50 per share. | 21 May 2026 | 300 | 45,172 (0%) | 0% | 562.5 | 168,750 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 566.05 per share. | 21 May 2026 | 270 | 45,472 (0%) | 0% | 566.1 | 152,834 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 559.99 per share. | 21 May 2026 | 200 | 52,512 (0%) | 0% | 560.0 | 111,998 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 555.72 per share. | 21 May 2026 | 110 | 53,362 (0%) | 0% | 555.7 | 61,129 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 556.70 per share. | 21 May 2026 | 10 | 53,352 (0%) | 0% | 556.7 | 5,567 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 07 May 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2026 | 8,300 | 300 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 587.61 per share. | 07 May 2026 | 2,970 | 46,264 (0%) | 0% | 587.6 | 1,745,198 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 586.17 per share. | 07 May 2026 | 1,689 | 49,234 (0%) | 0% | 586.2 | 990,045 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 584.07 per share. | 07 May 2026 | 1,475 | 51,917 (0%) | 0% | 584.1 | 861,503 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 585.18 per share. | 07 May 2026 | 994 | 50,923 (0%) | 0% | 585.2 | 581,667 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 588.51 per share. | 07 May 2026 | 820 | 45,444 (0%) | 0% | 588.5 | 482,577 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 597.54 per share. | 07 May 2026 | 202 | 45,172 (0%) | 0% | 597.5 | 120,703 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 582.86 per share. | 07 May 2026 | 80 | 53,392 (0%) | 0% | 582.9 | 46,629 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 596.19 per share. | 07 May 2026 | 70 | 45,374 (0%) | 0% | 596.2 | 41,733 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 16 Apr 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2026 | 8,300 | 8,600 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 577.39 per share. | 16 Apr 2026 | 3,366 | 46,466 (0%) | 0% | 577.4 | 1,943,488 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 576.38 per share. | 16 Apr 2026 | 1,800 | 49,832 (0%) | 0% | 576.4 | 1,037,493 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 575.37 per share. | 16 Apr 2026 | 1,640 | 51,632 (0%) | 0% | 575.4 | 943,605 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 578.21 per share. | 16 Apr 2026 | 1,294 | 45,172 (0%) | 0% | 578.2 | 748,204 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 574.04 per share. | 16 Apr 2026 | 200 | 53,272 (0%) | 0% | 574.0 | 114,807 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Apr 2026 | 8,300 | 16,900 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 02 Apr 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 566.66 per share. | 02 Apr 2026 | 1,629 | 48,175 (0%) | 0% | 566.7 | 923,096 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 567.55 per share. | 02 Apr 2026 | 1,403 | 46,772 (0%) | 0% | 567.5 | 796,267 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 564.55 per share. | 02 Apr 2026 | 1,115 | 50,347 (0%) | 0% | 564.6 | 629,476 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 562.34 per share. | 02 Apr 2026 | 774 | 51,833 (0%) | 0% | 562.3 | 435,254 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 569.61 per share. | 02 Apr 2026 | 710 | 45,372 (0%) | 0% | 569.6 | 404,424 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 568.79 per share. | 02 Apr 2026 | 690 | 46,082 (0%) | 0% | 568.8 | 392,468 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 565.66 per share. | 02 Apr 2026 | 543 | 49,804 (0%) | 0% | 565.7 | 307,152 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 560.30 per share. | 02 Apr 2026 | 514 | 52,958 (0%) | 0% | 560.3 | 287,992 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 563.58 per share. | 02 Apr 2026 | 371 | 51,462 (0%) | 0% | 563.6 | 209,087 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 561.69 per share. | 02 Apr 2026 | 351 | 52,607 (0%) | 0% | 561.7 | 197,152 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 571.60 per share. | 02 Apr 2026 | 200 | 45,172 (0%) | 0% | 571.6 | 114,321 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Mar 2026 | 8,300 | 25,200 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 19 Mar 2026 | 8,300 | 53,472 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 529.82 per share. | 19 Mar 2026 | 2,808 | 48,472 (0%) | 0% | 529.8 | 1,487,733 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 530.63 per share. | 19 Mar 2026 | 1,776 | 46,696 (0%) | 0% | 530.6 | 942,407 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 528.41 per share. | 19 Mar 2026 | 1,439 | 51,280 (0%) | 0% | 528.4 | 760,382 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 531.62 per share. | 19 Mar 2026 | 794 | 45,902 (0%) | 0% | 531.6 | 422,109 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 527.47 per share. | 19 Mar 2026 | 753 | 52,719 (0%) | 0% | 527.5 | 397,184 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 532.50 per share. | 19 Mar 2026 | 650 | 45,252 (0%) | 0% | 532.5 | 346,124 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 533.40 per share. | 19 Mar 2026 | 80 | 45,172 (0%) | 0% | 533.4 | 42,672 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 8,895 | 45,739 (0%) | 0% | - | Common Stock | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 8,895 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 7,796 | 0 | - | - | Restricted Stock Units | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2026 | 7,796 | 53,535 (0%) | 0% | - | Common Stock | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 536.12 per share. | 15 Mar 2026 | 4,457 | 49,078 (0%) | 0% | 536.1 | 2,389,487 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 536.12 per share. | 15 Mar 2026 | 3,906 | 45,172 (0%) | 0% | 536.1 | 2,094,085 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 05 Feb 2026 | 8,300 | 45,081 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Feb 2026 | 8,300 | 50,100 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.92 per share. | 05 Feb 2026 | 2,748 | 38,390 (0%) | 0% | 483.9 | 1,329,824 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 481.93 per share. | 05 Feb 2026 | 2,363 | 42,241 (0%) | 0% | 481.9 | 1,138,810 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 482.57 per share. | 05 Feb 2026 | 1,103 | 41,138 (0%) | 0% | 482.6 | 532,272 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 484.92 per share. | 05 Feb 2026 | 934 | 37,456 (0%) | 0% | 484.9 | 452,911 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.52 per share. | 05 Feb 2026 | 675 | 36,781 (0%) | 0% | 485.5 | 327,725 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 480.92 per share. | 05 Feb 2026 | 477 | 44,604 (0%) | 0% | 480.9 | 229,398 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 8,300 | 58,400 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 15 Jan 2026 | 8,300 | 45,081 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 469.34 per share. | 15 Jan 2026 | 3,531 | 38,397 (0%) | 0% | 469.3 | 1,657,237 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 471.44 per share. | 15 Jan 2026 | 1,576 | 36,821 (0%) | 0% | 471.4 | 742,990 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 468.32 per share. | 15 Jan 2026 | 1,439 | 43,642 (0%) | 0% | 468.3 | 673,918 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 470.37 per share. | 15 Jan 2026 | 1,307 | 42,335 (0%) | 0% | 470.4 | 614,769 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 472.28 per share. | 15 Jan 2026 | 407 | 41,928 (0%) | 0% | 472.3 | 192,219 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 474.75 per share. | 15 Jan 2026 | 40 | 36,781 (0%) | 0% | 474.8 | 18,990 | Common Stock |
| United Therapeutics Corp | A. Mahon Paul | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 02 Jan 2026 | 8,300 | 45,081 (0%) | 0% | 146.0 | 1,212,049 | Common Stock |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jan 2026 | 8,300 | 66,700 | - | - | Stock Option | |
| United Therapeutics Corp | Mahon Paul A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 487.76 per share. | 02 Jan 2026 | 2,181 | 36,981 (0%) | 0% | 487.8 | 1,063,803 | Common Stock |
| United Therapeutics Corp | A. Paul Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 485.68 per share. | 02 Jan 2026 | 1,509 | 40,292 (0%) | 0% | 485.7 | 732,894 | Common Stock |
| United Therapeutics Corp | Paul Mahon A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 484.54 per share. | 02 Jan 2026 | 1,240 | 41,801 (0%) | 0% | 484.5 | 600,825 | Common Stock |
| United Therapeutics Corp | Mahon A. Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 486.85 per share. | 02 Jan 2026 | 1,130 | 39,162 (0%) | 0% | 486.8 | 550,136 | Common Stock |
| United Therapeutics Corp | A. Mahon Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 481.26 per share. | 02 Jan 2026 | 822 | 44,259 (0%) | 0% | 481.3 | 395,595 | Common Stock |
| United Therapeutics Corp | Paul Mahon A. | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 483.35 per share. | 02 Jan 2026 | 739 | 43,041 (0%) | 0% | 483.3 | 357,195 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 481.83 per share. | 02 Jan 2026 | 479 | 43,780 (0%) | 0% | 481.8 | 230,797 | Common Stock |
| United Therapeutics Corp | Mahon A. Paul | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 489.15 per share. | 02 Jan 2026 | 200 | 36,781 (0%) | 0% | 489.2 | 97,830 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.03 per share. | 24 Dec 2025 | 11,000 | 47,781 (0%) | 0% | 146.0 | 1,606,330 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Dec 2025 | 11,000 | 9,250 | - | - | Stock Option | |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 513.46 per share. | 24 Dec 2025 | 4,713 | 39,511 (0%) | 0% | 513.5 | 2,419,948 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 512.59 per share. | 24 Dec 2025 | 2,877 | 44,224 (0%) | 0% | 512.6 | 1,474,726 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 514.18 per share. | 24 Dec 2025 | 2,650 | 36,861 (0%) | 0% | 514.2 | 1,362,589 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 509.22 per share. | 24 Dec 2025 | 502 | 47,279 (0%) | 0% | 509.2 | 255,627 | Common Stock |
| United Therapeutics Corp | Paul A. Mahon | EVP & GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 509.81 per share. | 24 Dec 2025 | 138 | 47,141 (0%) | 0% | 509.8 | 70,354 | Common Stock |